col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: International Immunopharmacology
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―23 Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: A preclinical tolerance study Suzan M. Mansour, Rehab N. Shamma, Kawkab A. Ahmed, Nirmeen A. Sabry, Gamal Esmat, Azza A. Mahmoud, Amr Maged
2 [GO] 2021―Jul―21 Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity Mahda Delshad, Ava Safaroghli-Azar, Atieh Pourbagheri-Sigaroodi, Behzad Poopak, Shervin Shokouhi, Davood Bashash
3 [GO] 2021―Jul―15 Corrigendum to “A pilot study for treatment of COVID-19 patients in moderate stage using intravenous administration of ozonized saline as an adjuvant treatment-registered clinical trial” [Int. Immunopharmacol. 96 (2021) 107743] Alok Sharma, Mili Shah, Satya Lakshmi, Hemangi Sane, Jignasha Captain, Nandini Gokulchandran, et al. (+11)
4 [GO] 2021―Jul―10 Umifenovir in Hospitalized Moderate to Severe COVID-19 Patients: A Randomized Clinical Trial Ilad Alavi Darazam, Shervin Shokouhi, Masoud Mardani, Mohamad Amin Pourhoseingholi, Mohammad Mahdi Rabiei, Firouze Hatami, et al. (+16)
5 [GO] 2021―Jul―10 Autoimmune Phenomena Following SARS-CoV-2 Vaccination Yuval Ishay, Ariel Kenig, Tehila Tsemach-Toren, Radgonde Amer, Limor Rubin, Yoav Hershkovitz, Fadi Kharouf
6 [GO] 2021―Jul―07 Evaluation of Adalimumab Effects in Managing Severe Cases of COVID-19: A Randomized Controlled Trial Atefeh Fakharian, Saghar Barati, Maryam Mirenayat, Mitra Rezaei, Hamidreza Jamaati, Sara Haseli, et al. (+5)
7 [GO] 2021―Jun―29 An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: the COVIFERONII randomized controlled trial Ilad Alavi Darazam, Firouze Hatami, Mohammad Mahdi Rabiei, Mohamad Amin Pourhoseingholi, Minoosh Shabani, Shervin Shokouhi, et al. (+10)
8 [GO] 2021―Jun―16 Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting Rajesh Naidu Janapal, Jigar Patel, Omar Belfaqeeh, Ali Pourmand
9 [GO] 2021―Jun―16 Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: A prospective longitudinal cohort study Ghobad Moradi, Amjad Mohamadi Bolbanabad, Sanaz Ahmadi, Abbas Aghaei, Fares Bahrami, Arshad Veysi, et al. (+5)
10 [GO] 2021―Jun―15 The Risk Factors and Related Hospitalizations for Cases with Positive and Negative COVID-19 Tests: A Case-Control Study Mostafa Ghanei, Hossein Keyvani, Aliakbar Haghdoost, Hassan Abolghasemi, Ghasem Janbabaei, Hamdi Reza Jamshidi, et al. (+4)
11 [GO] 2021―Jun―14 A SINGLE CENTER EXPERIENCE OF INTRAVENOUS IMMUNOGLOBULIN TREATMENT IN COVID-19 Ahmet Omma, Abdulsamet Erden, Berkan Armağan, Serdar Can Güven, Özlem Karakaş, Enes Seyda Şahiner, et al. (+4)
12 [GO] 2021―Jun―14 Seroprevalence of SARS-CoV-2 antibodies among hospital staff in rural Central Fukushima, Japan: a historical cohort study Yurie Kobashi, Yoshitaka Nishikawa, Takeshi Kawamura, Tatsuhiko Kodama, Yuzo Shimazu, Daiji Obara, et al. (+2)
13 [GO] 2021―Jun―12 Mometasone furoate nasal spray in the treatment of patients with COVID-19 olfactory dysfunction: A randomized, double blind clinical trial Hossein Kasiri, Nima Rouhani, Ebrahim Salehifar, Monireh Ghazaeian, Sahar Fallah
14 [GO] 2021―Jun―12 CORonavirus-19 mild to moderate pneumonia Management with blood Ozonization in patients with Respiratory failure (CORMOR) multicentric prospective randomized clinical trial Emanuela Sozio, Amato De Monte, Giovanni Sermann, Flavio Bassi, Davide Sacchet, Francesco Sbrana, et al. (+7)
15 [GO] 2021―Jun―02 The Effectiveness of Blood Routine Parameters and Some Biomarkers as a Potential Diagnostic Tool in the Diagnosis and Prognosis of Covid-19 Disease Mehmet Tahir Huyut, Fatih Ilkbahar
16 [GO] 2021―Jun―02 Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5in COVID-19 severity Elías Cuesta-Llavona, Juan Gómez, Guillermo M. Albaiceta, Laura Amado-Rodríguez, Marta García-Clemente, José Gutiérrez-Rodríguez, et al. (+13)
17 [GO] 2021―May―28 Comment on: Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia Seyed MohammadReza Hashemian, Batoul Khoundabi, Ali Akbar Velayati
18 [GO] 2021―May―24 Advanced glycation end products (AGEs) and its receptor, RAGE, modulate age-dependent COVID-19 morbidity and mortality. A review and hypothesis Durai Sellegounder, Parisa Zafari, Misagh Rajabinejad, Mahdi Taghadosi, Pankaj Kapahi
19 [GO] 2021―May―19 Characteristics of patients with kidney injury associated with COVID-19 Chunjin Ke, Jun Xiao, Zhihua Wang, Chong Yu, Chunguang Yang, Zhiquan Hu
20 [GO] 2021―May―19 The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-γ production in vitro Jinglu Lyu, Lirong Bao, Xin Shen, Caixia Yan, Cheng Zhang, Wei Wei, et al. (+6)
21 [GO] 2021―May―11 Insights on the mechanisms of action of ozone in the medical therapy against COVID-19 Salvatore Chirumbolo, Luigi Valdenassi, Vincenzo Simonetti, Dario Bertossi, Giovanni Ricevuti, Marianno Franzini, Sergio Pandolfi
22 [GO] 2021―May―09 Intragastric and atomized administration of canagliflozin inhibit inflammatory cytokine storm in lipopolysaccharide-treated sepsis in mice: a potential COVID-19 treatment Yaoyun Niu, Yang Chen, Pengbo Sun, Yangyang Wang, Jingyi Luo, Yipei Ding, Weidong Xie
23 [GO] 2021―May―06 An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages Hamid Motamedi, Marzie Mahdizade Ari, Shirin Dashtbin, Matin Fathollahi, Hadi Hossain pour, Amirhoushang Alvandi, et al. (+2)
24 [GO] 2021―Apr―30 Efficacy of IVIG (Intravenous Immunoglobulin) for Corona Virus Disease 2019 (COVID-19): a meta-analysis Huai-rong Xiang, Xuan Cheng, Yun Li, Wen-wen Luo, Qi-zhi Zhang, Wen-xing Peng
25 [GO] 2021―Apr―30 A Pilot study for treatment of COVID-19 patients in moderate stage using Intravenous administration of Ozonized saline as an adjuvant treatment- Registered Clinical Trial Alok Sharma, Mili Shah, Satya Lakshmi, Hemangi Sane, Jignasha Captain, Nandini Gokulchandran, et al. (+11)
26 [GO] 2021―Apr―28 Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities Susan Moradinasab, Atieh Pourbagheri-Sigaroodi, Parisa Zafari, Seyed H. Ghaffari, Davood Bashash
27 [GO] 2021―Apr―27 COVID-19 vaccine hesitancy and related fears and anxiety Antonia Bendau, Jens Plag, Moritz Bruno Petzold, Andreas Ströhle
28 [GO] 2021―Apr―27 Colchicine and Mortality in patients with Coronavirus Disease 2019 (COVID-19) pneumonia: A Systematic Review, Meta-analysis, and Meta-regression Eka Noneng Nawangsih, Yudith Yunia Kusmala, Iis Inayati Rakhmat, Dewi Ratih Handayani, Henny Juliastuti, Arief Wibowo, et al. (+2)
29 [GO] 2021―Apr―21 Hematological characteristics of patients with novel coronavirus pneumonia in intensive care unit Yong Du, Zhanjun Lu, Jing Jin, Tianyun Shi, Yi Ding, Ling Qian, et al. (+7)
30 [GO] 2021―Apr―21 Evaluating the elimination status of medications used for COVID-19 during hemoperfusion and therapeutic plasma exchange: A review Shervin Shokouhi, Saghar Barati, Neda Kazeminia, Faezeh Jamali, Baran Roshan, Zahra Sahraei
31 [GO] 2021―Apr―21 Evaluation of hepatic enzymes activities in COVID-19 patients Rundk Hwaiz, Mohammed Merza, Badraldin Hamad, Shirin HamaSalih, Mustafa Mohammed, Harmand Hama
32 [GO] 2021―Apr―21 Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trial Hong Zhao, Chi Zhang, Qi Zhu, Xianxiang Chen, Guilin Chen, Wenjin Sun, et al. (+19)
33 [GO] 2021―Apr―19 A Possible Pathogenic Role of Syndecan-1 in the Pathogenesis of Coronavirus Disease 2019 (COVID-19) Sajad Karampoor, Hamid Zahednasab, Mohammad Farahmand, Rasoul Mirzaei, Farhad Zamani, Alireza Tabibzadeh, et al. (+6)
34 [GO] 2021―Apr―19 Immunological and inflammatory profiles during acute and convalescent phases of severe/ critically ill COVID-19 patients Qigao Chen, Baodan Yu, Yihao Yang, Jiewen Huang, Ying Liang, Jing Zhou, et al. (+4)
35 [GO] 2021―Apr―19 The role of vitamin D in reducing SARS-CoV-2 infection: An update Mohammad Shah Alam, Daniel M. Czajkowsky, Md. Aminul Islam, Md. Ataur Rahman
36 [GO] 2021―Apr―16 Essential Considerations During Vaccine Design against COVID-19 and Review of Pioneering Vaccine Candidate Platforms Maryam Bayat, Yahya Asemani, Sajad Najafi
37 [GO] 2021―Apr―06 Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting Majid Mokhtari, Minoo Mohraz, Mohammad Mehdi Gouya, Hengameh Namdari Tabar, Katayoun Tayeri, Saeide Aghamohamadi, et al. (+5)
38 [GO] 2021―Apr―06 Acute and Post-Acute Phase of Covid-19: Analyzing Expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and Let-7b-3p in PBMC Tahereh Donyavi, Farah Bokharaei-Salim, Hossein Bannazadeh Baghi, Khadijeh Khanaliha, Mahrokh Alaei Janat-Makan, Bahareh Karimi, et al. (+6)
39 [GO] 2021―Apr―02 Immunopharmacological Perspective on Zinc in SARS-CoV-2 Infection Sima Heydarzadeh Asl, Sepideh Nikfarjam, Naime Majidi Zolbanin, Reza Nassiri, Reza Jafari
40 [GO] 2021―Apr―02 Individual risk management strategy for SARS-CoV2 infection: a step toward personalized healthcare Torsak Tippairote, Massimiliano Peana, Salvatore Chirumbolo, Geir Bjørklund
41 [GO] 2021―Mar―29 Potential SARS-CoV-2 Vaccines: Concept, Progress, and Challenges Seyede Atefe Hosseini, Fatemeh Zahedipour, Hamed Mirzaei, Reza Kazemi Oskuee
42 [GO] 2021―Mar―27 Identification of COVID-19 Subtypes Based on Immunogenomic Profiling Zuobing Chen, Qiushi Feng, Tianfang Zhang, Xiaosheng Wang
43 [GO] 2021―Mar―24 The effect of tocilizumab on COVID-19 patient mortality: A systematic review and meta-analysis of randomized controlled trials Wei-Ting Lin, Shun-Hsing Hung, Chih-Cheng Lai, Cheng-Yi Wang, Chao-Hsien Chen
44 [GO] 2021―Mar―23 ACE2 correlates with immune infiltrates in colon adenocarcinoma: Implication for COVID-19 Mohsen Ahmadi, Salar Pashangzadeh, Pegah Mousavi, Negin Saffarzadeh, Mohammad Amin Habibi, Fatemeh Hajiesmaeili, Nima Rezaei
45 [GO] 2021―Mar―19 The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19 Mahda Delshad, Naeimeh Tavakolinia, Atieh Pourbagheri-Sigaroodi, Ava Safaroghli-azar, Nader Bagheri, Davood Bashash
46 [GO] 2021―Mar―14 The role of IL-6/lymphocyte ratio in the peripheral blood of severe patients with COVID-19 Boyi Yang, Xiaoyan Chang, Jiabao Huang, Wen Pan, Zhilong Si, Cuntai Zhang, Hong Li
47 [GO] 2021―Mar―14 Risk factors for SARS-CoV-2 re-positivity in COVID-19 patients after discharge Lu-Xiao Hong, Lian Liu, Aifen Lin, Wei-Hua Yan
48 [GO] 2021―Mar―14 The Potential for Lactoferrin to Reduce SARS-CoV-2 Induced Cytokine Storm Michał Zimecki, Jeffrey K. Actor, Marian L. Kruzel
49 [GO] 2021―Mar―12 Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia Masoud Solaymani-Dodaran, Mostafa Ghanei, Mehdi Bagheri, Ali Qazvini, Ensieh Vahedi, Seyed Hassan Saadat, et al. (+38)
50 [GO] 2021―Mar―11 Landscape of SARS-CoV-2 spike protein-interacting cells in human tissues Bingfeng Zheng, Manman Yuan, Qinhai Ma, Shenglan Wang, Yang Tan, Yizhu Xu, et al. (+8)
51 [GO] 2021―Mar―07 The role of probiotics in coronavirus disease-19 infection in Wuhan: A Retrospective study of 311 severe patients Qiang Li, Fang Cheng, Qiling Xu, Yuyong Su, Xuefeng Cai, Fang Zeng, Yu Zhang
52 [GO] 2021―Mar―02 Serum Amyloid A Protein as a useful biomarker to predict COVID-19 patients severity and prognosis Massimo Pieri, Marco Ciotti, Marzia Nuccetelli, Marco Alfonso Perrone, Maria Teresa Caliò, Maria Stella Lia, et al. (+2)
53 [GO] 2021―Feb―27 Covid-19 Challenges to Immune Investigations and Therapies James E Talmadge, Francois Marceau
54 [GO] 2021―Feb―26 An overview of some potential immunotherapeutic options against COVID-19 Maryam Bayat, Yahya Asemani, Mohammad Reza Mohammadi, Mahsa Sanaei, Mozhdeh Namvarpour, Reyhaneh Eftekhari
55 [GO] 2021―Feb―25 SARS-CoV-2: Insight in genome structure, pathogenesis and viral receptor binding analysis- An Updated Review Eijaz Ahmed Bhat, Johra khan, Nasreena Sajjad, Ahmad Ali, Fahad M. Aldakeel, Ayesha Mateen, et al. (+2)
56 [GO] 2021―Feb―17 Immune response of frontline medical workers providing medical support for Wuhan COVID-19 patients, China Juanjuan Yang, Qian Wang, Shuqun Zhang, Zongfang Li, Wei Jiang
57 [GO] 2021―Jan―29 Immune Response Scenario and Vaccine Development for SARS-CoV-2 Infection Mai H.S. Mohammad
58 [GO] 2021―Jan―28 Interferon-based therapies in COVID-19 Chia Siang Kow, Syed Shahzad Hasan
59 [GO] 2021―Jan―22 COVID-19 associated thrombotic thrombocytopenic purpura (TTP) ; A case series and mini-review Hamed Azhdari Tehrani, Maryam Darnahal, Mohammad Vaezi, Shirin Haghighi
60 [GO] 2021―Jan―22 Type 2 diabetes mellitus impaired nasal immunity and increased the risk of hyposmia in COVID-19 mild pneumonia patients Yi Zhao, Yujie Liu, Fangzheng Yi, Jun Zhang, Zhaohui Xu, Yehai Liu, Ye Tao
61 [GO] 2021―Jan―22 Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra Esmaeil Mortaz, Ali Bassir, Neda Dalil Roofchayee, Neda K. Dezfuli, Hamidreza Jamaati, Payam Tabarsi, et al. (+7)
62 [GO] 2021―Jan―22 Advances in Immunotherapy for COVID-19: a comprehensive review Masoumeh Masoumi Karimi, Behzad Garmabi, Javad Alizadeh, Erfan Kazemi, Amirhossein Azari Jafari, Mohammad Sadeq Mirmoeini, et al. (+3)
63 [GO] 2021―Jan―12 An overview of Betacoronaviruses-associated severe respiratory syndromes, focusing on sex-type-specific immune responses Golbarg Rahimi, Bahareh Rahimi, Mohammad Panahi, Shadi Abkhiz, Neda Saraygord-Afshari, Morteza Milani, Effat Alizadeh
64 [GO] 2021―Jan―10 Different characteristics of critical COVID-19 and thinking of treatment strategies in non-elderly and elderly severe adult patients Zhelong Liu, Danning Wu, Xia Han, Wangyan Jiang, Lin Qiu, Rui Tang, Xuefeng Yu
65 [GO] 2021―Jan―10 Immunology, Immunopathogenesis and Immunotherapeutics of COVID-19; an Overview Leila Mohamed Khosroshahi, Mohsen Rokni, Tahmineh Mokhtari, Farshid Noorbakhsh
66 [GO] 2020―Dec―30 A review on the effect of COVID-19 in type 2 asthma and its management Srijit Ghosh, Srijita Das, Rupsa Mondal, Salik Abdullah, Shirin Sultana, Sukhbir Singh, et al. (+2)
67 [GO] 2020―Dec―30 The difference between IgM and IgG antibody prevalence in different serological assays for COVID-19; lessons from the examination of healthcare workers Yurie Kobashi, Yuzo Shimazu, Yoshitaka Nishikawa, Takeshi Kawamura, Tatsuhiko Kodama, Daiji Obara, Masaharu Tsubokura
68 [GO] 2020―Dec―28 Could cilostazol be beneficial in COVID-19 treatment? Thinking about phosphodiesterase-3 as a therapeutic target Nadia Alice Vieira Motta, Lis Jappour Autran, Stephani Correia Brazão, Rosane de Oliveira Lopes, Christianne Brêtas Vieira Scaramello, Gabriel Ferreira Lima, Fernanda Carla Ferreira de Brito
69 [GO] 2020―Dec―26 Combination therapy of IFNβ1 with lopinavir-ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients Parvaneh Baghaei, Farzaneh Dastan, Majid Marjani, Afshin Moniri, Zahra Abtahian, Somayeh Ghadimi, et al. (+11)
70 [GO] 2020―Dec―24 The role of serum specific- SARS-CoV-2 antibody in patients with COVID-19 Hao Chen, Xinyu Zhang, Wanjun Liu, Mingshan Xue, Chenxi Liao, Zhifeng Huang, et al. (+2)
71 [GO] 2020―Dec―23 Safety and efficacy of ozone therapy in mild to moderate COVID-19 patients: A Phase 1/11 Randomized control Trial (SEOT study) Mili Shah, Jignasha Captain, Vidyadhar Vaidya, Arvind Kulkarni, Kedar Valsalkar, Pradeep M.K. Nair, Gayatri Ganu
72 [GO] 2020―Dec―21 Ozone therapy for the treatment of COVID-19 pneumonia: a scoping review Morteza Izadi, Luca Cegolon, Mohammad Javanbakht, Ali Sarafzadeh, Hassan Abolghasemi, Gholamhossein Alishiri, et al. (+11)
73 [GO] 2020―Dec―17 Genome-wide Analysis of Indian SARS-CoV-2 Genomes to Identify T-cell and B-cell Epitopes from Conserved Regions based on Immunogenicity and Antigenicity Nimisha Ghosh, Nikhil Sharma, Indrajit Saha, Sudipto Saha
74 [GO] 2020―Dec―12 “Diagnostic utility of C-reactive protein to albumin ratio as an early warning sign in hospitalized severe COVID-19 patients ” Inanc Karakoyun, Ayfer Colak, Melda Turken, Zeynep Altın, Fatma Demet Arslan, Veli Iyilikci, et al. (+2)
75 [GO] 2020―Dec―09 Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients Yanan Wang, Jingjing Li, Huijun Li, Ping Lei, Guanxin Shen, Chunguang Yang
76 [GO] 2020―Dec―05 Ozone therapy for patients with COVID-19 pneumonia: preliminary report of a prospective case-control study Alberto Hernández, Asunción Pablos, Peter J Papadakos, Sergio D. Bergese, Marc Vives
77 [GO] 2020―Dec―05 Convalescent plasma may be a possible treatment for COVID-19: A systematic review Ying Wang, Pengfei Huo, Rulin Dai, Xin Lv, Shaofei Yuan, Yang Zhang, et al. (+4)
78 [GO] 2020―Dec―02 COVID-19 and Cancer: From basic mechanisms to vaccine development using nanotechnology Hyun Jee Han, Chinekwu Nwagwu, Obumneme Anyim, Chinedu Ekweremadu, San Kim
79 [GO] 2020―Dec―02 Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome Abolghasem Allahyari, Mohsen Seddigh-Shamsi, Mahmoud Mahmoudi, Saeid Amel Jamehdar, Mahnaz Amini, Mahnaz Mozdourian, et al. (+17)
80 [GO] 2020―Dec―01 Interferon-inducer antivirals: potential candidates to combat COVID-19 Ashkan Bagheri, Seyed Mohammad Iman Moezzi, Pouria Mosaddeghi, Sadra Nadimi Parashkouhi, Seyed Mostafa Fazel Hoseini, Fatemeh Badakhshan, Manica Negahdaripour
81 [GO] 2020―Nov―30 Neutrophils and COVID-19: The road so far Luiz Henrique Agra Cavalcante-Silva, Deyse Cristina Madruga Carvalho, Éssia de Almeida Lima, José G.F.M. Galvão, Juliane S. de França da Silva, José M. de Sales-Neto, Sandra Rodrigues-Mascarenhas
82 [GO] 2020―Nov―27 The Deregulated Immune Reaction and Cytokines Release Storm (CRS) in COVID-19 disease Ritu Pasrija, Mohammad Naime
83 [GO] 2020―Nov―27 Therapeutic Drugs for SARS-CoV-2 Treatment: Current State and Perspective Bolarin Joshua Adedeji, Oluwatoyosi Mercy Adaramodu, Joshua Iseoluwa Orege, Ayeni Emmanuel Ayodeji, Ibrahim Yusuf Ajibola, Adeyemi Sherif Babatunde, et al. (+6)
84 [GO] 2020―Nov―26 Pentoxifylline decreases serum LDH levels and increases lymphocyte count in COVID-19 patients: results from an external pilot study Valente Maldonado, Claudia Hernandez-Ramírez, Eniel Alonso Oliva-Pérez, César Omar Sánchez-Martínez, Jorge Fabián Pimentel-González, José Raúl Molina-Sánchez, et al. (+3)
85 [GO] 2020―Nov―20 COVID-19 and Hyperimmune sera: a feasible plan B to fight against coronavirus Camila B P da Costa, Francislene J Martins, Luis E R da Cunha, Norman A. Ratcliffe, Rafael Cisne de Paula, Helena C Castro
86 [GO] 2020―Nov―13 Evaluating the Effects of Intravenous Immunoglobulin (IVIg) on the Management of Severe COVID-19 Cases: A Randomized Controlled Trial Payam Tabarsi, Saghar Barati, Hamidreza Jamaati, Sara haseli, Majid Marjani, Afshin Moniri, et al. (+8)
87 [GO] 2020―Nov―13 The emerging role of microRNAs in the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection Rasoul Mirzaei, Farzad Mahdavi, Fariba Badrzadeh, Seyed Reza Hosseini-Fard, Maryam Heidary, Ali Salimi Jeda, et al. (+7)
88 [GO] 2020―Nov―10 Epicardial Adipose Tissue, Inflammatory Biomarkers and COVID-19: Is There a Possible Relationship? Alireza Abrishami, Vahid Eslami, Zahra Baharvand, Nastaran Khalili, Somayeh Saghamanesh, Ehsan Zarei, Morteza Sanei-Taheri
89 [GO] 2020―Nov―03 Clinical characteristics and antibiotics treatment in suspected bacterial infection patients with COVID-19 Chengyin Liu, Ying Wen, Weiguo Wan, Jingchao Lei, Xuejun Jiang
90 [GO] 2020―Nov―03 Associations of Medications Used during Hospitalization and Immunological Changes in Patients with COVID-19 During 3-Month Follow-up Chao Liu, Yaoshan Dun, Ping Liu, Baiyang You, Kongliang Shu, Huijun Luo, et al. (+4)
91 [GO] 2020―Nov―03 Potential role of interferons in treating COVID-19 patients Mohadeseh Haji Abdolvahab, Shima Moradi-kalbolandi, Mohammad Zarei, Deepanwita Bose, Keivan Majidzadeh-A, Leila Farahmand
92 [GO] 2020―Nov―03 Acute kidney injury and renal replacement therapy in COVID-19 patients: a systematic review and meta-analysis Xiaopeng Yang, Shasha Tian, Hui Guo
93 [GO] 2020―Nov―03 Exploring the Multifocal Therapeutic Approaches in COVID-19: A Ray of Hope Arun Kumar, Asmita Deka Dey, Tapan Behl, Swati Chadha, Vishal Aggarwal
94 [GO] 2020―Nov―03 Chicken Egg Yolk Antibodies (IgYs) block the binding of Multiple SARS-CoV-2 Spike protein variants to human ACE2 Shuangshi Wei, Shengbao Duan, Xiaomei Liu, Hongmei Wang, Shaohua Ding, Yezhou Chen, et al. (+8)
95 [GO] 2020―Oct―31 Application value of artificial liver support system in the treatment of cytokine storm in patients with COVID-19 Qi Xia, Kaijin Xu, Liang Yu, Huafen Zhang, Lanjuan Li
96 [GO] 2020―Oct―31 The effect of Thymosin α1 on mortality of critical COVID-19 patients: A multicenter retrospective study Qin Sun, Jianfeng Xie, Ruiqiang Zheng, Xuyan Li, Hui Chen, Zhaohui Tong, et al. (+3)
97 [GO] 2020―Oct―20 Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients Hamed Valizadeh, Samaneh Abdolmohammadi-vahid, Svetlana Danshina, Mehmet Ziya Gencer, Ali Ammari, Armin Sadeghi, et al. (+6)
98 [GO] 2020―Oct―13 Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial Reza Malekzadeh, Atefeh Abedini, Behzad Mohsenpour, Ehsan Sharifipour, Roya Ghasemian, Seyed Ali Javad-Mousavi, et al. (+13)
99 [GO] 2020―Oct―12 Nucleic acid and antibody assay results in Chinese patients with coronavirus disease 2019 (COVID-19) Yong Lu, Yongyan Li, Yiping Wang, Jianping Luo, Wanjun Yu
100 [GO] 2020―Oct―10 Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics Negin Ebrahimi, Saeed Aslani, Farhad Babaie, Maryam Hemmatzadeh, Ramin Hosseinzadeh, Zeinab Joneidi, et al. (+3)
101 [GO] 2020―Oct―05 Decreased complement C3 levels are associated with poor prognosis in patients with COVID-19: A retrospective cohort study Shilin Fang, Haizhou Wang, Li Lu, Yifan Jia, Zhongyuan Xia
102 [GO] 2020―Oct―03 Novel Serological Biomarkers for Inflammation in Predicting Disease Severity in Patients with COVID-19 Guohui Xue, Xing Gan, Zhiqiang Wu, Dan Xie, Yan Xiong, Lin Hua, et al. (+4)
103 [GO] 2020―Sep―29 The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies Soheila Molaei, Masoomeh Dadkhah, Vahid Asghariazar, Chiman Karami, Elham Safarzadeh
104 [GO] 2020―Sep―25 Continuous tracking of COVID-19 patients' immune status Jingjing Guan, Xin Wei, Shuang Qin, Xiaoyuan Liu, Yujie Jiang, Yingxiao Chen, et al. (+5)
105 [GO] 2020―Sep―23 Risk Factors for Prolonged Viral Clearance in Adult Patients with COVID-19 in Beijing, China: A Prospective Observational Study Jian Xue, Jing Zheng, Xueyi Shang, Enqiang Qin, Peng Zhao, Yuan He, et al. (+4)
106 [GO] 2020―Sep―18 Gender-Associated Difference following COVID-19 virus infection: Implications for Thymosin alpha-1 Therapy Xin Li, Lancong Liu, Yi Yang, Xuefeng Yang, Cengceng Wang, Yan Li, et al. (+6)
107 [GO] 2020―Sep―16 Tocilizumab for treatment patients with COVID-19: recommended medication for novel disease Hamidreza Samaee, Monireh Mohsenzadegan, Shahram Ala, Shahnam Sedigh Maroufi, Parisa Moradimajd
108 [GO] 2020―Sep―14 Lower levels of vitamin D are associated with SARS-CoV-2 infection and mortality in the Indian population: an observational study Sunali Padhi, Subham Suvankar, Venketesh K. Panda, Abhijit Pati, Aditya K Panda
109 [GO] 2020―Sep―11 Correlation between premorbid IL-6 levels and COVID-19 mortality: Potential role for Vitamin D Morry Silberstein
110 [GO] 2020―Sep―09 Clinical and laboratory features of COVID-19: Predictors of severe prognosis Aliye Bastug, Hurrem Bodur, Serpil Erdogan, Derya Gokcinar, Sumeyye Kazancioglu, Behiye Deniz Kosovali, et al. (+6)
111 [GO] 2020―Sep―08 Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics V. Kumar
112 [GO] 2020―Aug―31 Drug repurposing and cytokine management in response to COVID-19: a review Luana Heimfarth, Mairim Russo Serafini, Paulo Ricardo Saquete Martins-Filho, Jullyana Souza Siqueira Quintans, Lucindo José Quintans Júnior
113 [GO] 2020―Aug―29 Immunomodulatory-Based Therapy as a Potential Promising Treatment Strategy against Severe COVID-19 Patients: A Systematic Review Mahdieh Razmi, Farideh Hashemi, Elmira Gheytanchi, Masoumeh Dehghan, Roya Ghods, Zahra Madjd
114 [GO] 2020―Aug―28 Outcome of COVID-19 Patients with Use of Tocilizumab: a single center experience Muhammad Zain Mushtaq, Saad Bin Zafar Mahmood, Bushra Jamil, Adil Aziz, Syed A. Ali
115 [GO] 2020―Aug―24 Interferon β-1b in treatment of severe COVID-19: a randomized clinical trial Hamid Rahmani, Effat Davoudi-Monfared, Anahid Nourian, Hossein Khalili, Nooshin Hajizadeh, Narjes zarei Jalalabadi, et al. (+3)
116 [GO] 2020―Aug―24 Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine Rasoul Mirzaei, Rokhsareh Mohammadzadeh, Farzad Mahdavi, Fariba Badrzadeh, Sheida Kazemi, Mehdi Ebrahimi, et al. (+7)
117 [GO] 2020―Aug―21 Immunotherapeutic approaches to curtail COVID-19 Hajar Owji, Manica Negahdaripour, Nasim Hajighahramani
118 [GO] 2020―Aug―19 Association between NLR and COVID-19 Serdar Kalemci, Aydın Sarıhan, Arife Zeybek
119 [GO] 2020―Aug―08 Coronavirus Disease 2019 (COVID-19): Immunological Approaches and Emerging Pharmacologic Treatments Pedram Goodarzi, Farzad Mahdavi, Rasoul Mirzaei, Hamze Hasanvand, Mohammad Sholeh, Farhad Zamani, et al. (+6)
120 [GO] 2020―Aug―08 Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported Marianno Franzini, Luigi Valdenassi, Giovanni Ricevuti, Salvatore Chirumbolo, Markus Depfenhart, Dario Bertossi, Umberto Tirelli
121 [GO] 2020―Aug―06 Thymosin α1 Therapy in Critically Ill Patients with COVID-19: a Multicenter Retrospective Cohort Study Ming Wu, Jing-jing Ji, Li Zhong, Zi-yun Shao, Qi-feng Xie, Zhe-ying Liu, et al. (+5)
122 [GO] 2020―Aug―04 Promising Effects of Tocilizumab in COVID-19: A Non-Controlled, Prospective Clinical Trial Farzaneh Dastan, Ali Saffaei, Sara Haseli, Majid Marjani, Afshin Moniri, Zahra Abtahian, et al. (+16)
123 [GO] 2020―Jul―30 Serological detection of 2019-nCoV respond to the epidemic: A useful complement to nucleic acid testing Jin Zhang, Xiaoming Zhang, Jianhua Liu, Yuan Ban, Na Li, Yunhai Wu, et al. (+7)
124 [GO] 2020―Jul―01 Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19 Xiuhong Zhang, Yan Zhang, Weizhen Qiao, Ji Zhang, Zhigang Qi
125 [GO] 2020―Jun―28 Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A Systematic Review Zahra Noorimotlagh, Chiman Karami, Seyyed Abbas Mirzaee, Mohammadreza Kaffashian, Sanaz Mami, Mahdieh Azizi
126 [GO] 2020―Jun―26 Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis Rui Liu, Xinghui Liu, Li Yuan, Huan Han, Muhammad Adnan Shereen, Jiesheng Zhen, et al. (+6)
127 [GO] 2020―Jun―25 Evaluation of safety, efficacy, tolerability, and treatment-related outcomes of type I interferons for Human coronaviruses (HCoVs) infection in clinical practice: An updated critical systematic review and meta-analysis Chengjun Yu, Lian Kang, Jiadong Chen, Na Zang
128 [GO] 2020―Jun―24 Cold-inducible RNA-binding protein (CIRBP) promotes porcine reproductive and respiratory syndrome virus (PRRSV)-induced inflammatory response Xiao Xiao, Wentao Zhang, Deping Hua, Lilin Zhang, Wei Meng, Jinhai Huang, Lei Zhang
129 [GO] 2020―Jun―18 Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses Tania Gupta, Shishir K Gupta
130 [GO] 2020―Jun―16 Use of machine learning and artificial intelligence to predict SARS-CoV-2 infection from full blood counts in a population Abhirup Banerjee, Surajit Ray, Bart Vorselaars, Joanne Kitson, Michail Mamalakis, Simonne Weeks, Louise S. Mackenzie
131 [GO] 2020―Jun―07 Subcutaneous administration of Interferon beta-1a for COVID-19: A non-controlled prospective trial Farzaneh Dastan, Seyed Alireza Nadji, Ali Saffaei, Majid Marjani, Afshin Moniri, Hamidreza Jamaati, et al. (+6)
132 [GO] 2020―Jun―06 Neutrophil to CD4+ lymphocyte ratio as a potential biomarker in predicting virus negative conversion time in COVID-19 Haizhou Wang, Yongxi Zhang, Pingzheng Mo, Jing Liu, Hongling Wang, Fan Wang, Qiu Zhao
133 [GO] 2020―May―08 Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids Amene Saghazadeh, Nima Rezaei
134 [GO] 2020―Apr―16 SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment Scavone Cristina, Rafaniello Concetta, Rossi Francesco, Capuano Annalisa
135 [GO] 2020―Apr―13 The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients Ai-Ping Yang, Jian-ping Liu, Wen-qiang Tao, Hui-ming Li
136 [GO] 2020―Apr―02 The possible of immunotherapy for COVID-19: A systematic review Akram AminJafari, Sorayya Ghasemi


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.005 sec